This activity is expired and is no longer available for CME credit.


CATT and IVAN Studies

Author(s)/Faculty: Szilard Kiss, MD
Release Date: 12/1/2012Expiration Date: 12/1/2013
Credit Type: CMENumber of Credits: 0
Content Type: Provider:
The development of agents capable of inhibiting the angiogenic signaling protein vascular endothelial growth factor (VEGF) heralded a revolution in the treatment of proliferative retinal diseases, particularly neovascular, or “wet,” age-related macular degeneration (AMD)...